Encompass Health Corporation EHC
136.04 USD -1.16 (-0.84%)
Nov 3, 2026, 3:26 PM EST
135.65 Day range 139.12
92.77 52-week range 139.12
- YTD
- +28.17%
- 1 year
- +17.20%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 154.83 +13.8% upside
Now 136.04
- Target (low)
- 140.00
- Target (mean)
- 154.83
- Target (high)
- 177.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy1
- Buy12
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.63 | 1.57 – 1.66 | 1.46 | +11.5% | 1.68B | +8.9% | 11 |
| Next quarter | 1.70 | 1.62 – 1.75 | 1.60 | +6.3% | 1.71B | +8.0% | 8 |
| Current year | 6.29 | 6.23 – 6.33 | 5.45 | +15.5% | 6.48B | +9.1% | 12 |
| Next year | 6.88 | 6.15 – 7.11 | 6.29 | +9.3% | 7.02B | +8.4% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Oct 30, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Oct 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 10, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 7, 2026 | UBS | Maintained | Buy | Buy |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 28, 2026 | TD Cowen | Initiated | — | Buy |
| May 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 2, 2025 | UBS | Maintained | Buy | Buy |
| Sep 16, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Sep 10, 2025 | B of A Securities | Maintained | Buy | Buy |
| Aug 14, 2025 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2025 | UBS | Maintained | Buy | Buy |
| Jun 5, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 27, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Apr 28, 2025 | UBS | Maintained | Buy | Buy |
| Apr 28, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 28, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Apr 25, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Apr 25, 2025 | Barclays | Maintained | Overweight | Overweight |
| Feb 11, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Feb 10, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Feb 7, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 30, 2024 | Truist Securities | Reiterated | Buy | Buy |
